SS
NVO

STG Securities’s Novo Nordisk NVO Stock Holding History

STG Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+5,059
New +$217K 0.02% 419

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

STG Securities's NVO Position: Q2 2026 in Review

STG Securities opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,059 shares worth $243K. The stake represents 0.02% of the portfolio and ranks #419 among its holdings.

1,346 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • STG Securities held 5,059 shares of Novo Nordisk worth $243K as of Q2 2026.
  • Novo Nordisk was a new STG Securities position in Q2 2026.
  • Novo Nordisk made up 0.02% of STG Securities's portfolio in Q2 2026, its #419 holding.
  • 1,346 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on STG Securities's 13F filing for Q2 2026, filed 13 Aug 2026.